vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and TTEC Holdings, Inc. (TTEC). Click either name above to swap in a different company.

TTEC Holdings, Inc. is the larger business by last-quarter revenue ($570.0M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -29.9%, a 36.7% gap on every dollar of revenue. On growth, TTEC Holdings, Inc. posted the faster year-over-year revenue change (0.4% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -0.6%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

TTEC Holdings, Inc., is an American customer experience technology and services company with its primary place of business in Austin, Texas.

MD vs TTEC — Head-to-Head

Bigger by revenue
TTEC
TTEC
1.2× larger
TTEC
$570.0M
$493.8M
MD
Growing faster (revenue YoY)
TTEC
TTEC
+2.2% gap
TTEC
0.4%
-1.7%
MD
Higher net margin
MD
MD
36.7% more per $
MD
6.8%
-29.9%
TTEC
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-0.6%
TTEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
TTEC
TTEC
Revenue
$493.8M
$570.0M
Net Profit
$33.7M
$-170.5M
Gross Margin
Operating Margin
9.9%
-30.3%
Net Margin
6.8%
-29.9%
Revenue YoY
-1.7%
0.4%
Net Profit YoY
10.5%
-3791.9%
EPS (diluted)
$0.40
$-3.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
TTEC
TTEC
Q4 25
$493.8M
$570.0M
Q3 25
$492.9M
$519.1M
Q2 25
$468.8M
$513.6M
Q1 25
$458.4M
$534.2M
Q4 24
$502.4M
$567.4M
Q3 24
$511.2M
$529.4M
Q2 24
$504.3M
$534.1M
Q1 24
$495.1M
$576.6M
Net Profit
MD
MD
TTEC
TTEC
Q4 25
$33.7M
$-170.5M
Q3 25
$71.7M
$-13.4M
Q2 25
$39.3M
$-8.0M
Q1 25
$20.7M
$1.4M
Q4 24
$30.5M
$4.6M
Q3 24
$19.4M
$-21.1M
Q2 24
$-153.0M
$-299.5M
Q1 24
$4.0M
$-2.3M
Operating Margin
MD
MD
TTEC
TTEC
Q4 25
9.9%
-30.3%
Q3 25
13.8%
2.4%
Q2 25
12.8%
3.7%
Q1 25
7.0%
4.5%
Q4 24
7.8%
2.7%
Q3 24
6.6%
2.4%
Q2 24
-31.3%
-42.0%
Q1 24
3.2%
3.9%
Net Margin
MD
MD
TTEC
TTEC
Q4 25
6.8%
-29.9%
Q3 25
14.5%
-2.6%
Q2 25
8.4%
-1.6%
Q1 25
4.5%
0.3%
Q4 24
6.1%
0.8%
Q3 24
3.8%
-4.0%
Q2 24
-30.3%
-56.1%
Q1 24
0.8%
-0.4%
EPS (diluted)
MD
MD
TTEC
TTEC
Q4 25
$0.40
$-3.57
Q3 25
$0.84
$-0.28
Q2 25
$0.46
$-0.17
Q1 25
$0.24
$0.03
Q4 24
$0.37
$0.05
Q3 24
$0.23
$-0.44
Q2 24
$-1.84
$-6.30
Q1 24
$0.05
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
TTEC
TTEC
Cash + ST InvestmentsLiquidity on hand
$375.2M
$82.9M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$112.9M
Total Assets
$2.2B
$1.5B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
TTEC
TTEC
Q4 25
$375.2M
$82.9M
Q3 25
$340.1M
$73.5M
Q2 25
$224.7M
$82.6M
Q1 25
$99.0M
$85.1M
Q4 24
$229.9M
$85.0M
Q3 24
$103.8M
$96.9M
Q2 24
$19.4M
$79.8M
Q1 24
$8.0M
$91.5M
Total Debt
MD
MD
TTEC
TTEC
Q4 25
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
TTEC
TTEC
Q4 25
$865.9M
$112.9M
Q3 25
$890.7M
$280.8M
Q2 25
$833.8M
$295.2M
Q1 25
$789.2M
$281.5M
Q4 24
$764.9M
$268.1M
Q3 24
$732.5M
$295.1M
Q2 24
$706.5M
$304.2M
Q1 24
$856.2M
$612.4M
Total Assets
MD
MD
TTEC
TTEC
Q4 25
$2.2B
$1.5B
Q3 25
$2.2B
$1.7B
Q2 25
$2.1B
$1.7B
Q1 25
$2.0B
$1.7B
Q4 24
$2.2B
$1.8B
Q3 24
$2.1B
$1.8B
Q2 24
$2.0B
$1.8B
Q1 24
$2.2B
$2.1B
Debt / Equity
MD
MD
TTEC
TTEC
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
TTEC
TTEC
Operating Cash FlowLast quarter
$114.1M
$2.6M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-1.6%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters
$83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
TTEC
TTEC
Q4 25
$114.1M
$2.6M
Q3 25
$137.3M
$4.2M
Q2 25
$137.2M
$92.7M
Q1 25
$-117.5M
$21.6M
Q4 24
$133.0M
$-1.1M
Q3 24
$91.8M
$-91.4M
Q2 24
$107.0M
$49.3M
Q1 24
$-125.2M
$-15.6M
Free Cash Flow
MD
MD
TTEC
TTEC
Q4 25
$-9.2M
Q3 25
$-9.6M
Q2 25
$85.5M
Q1 25
$16.2M
Q4 24
$-9.8M
Q3 24
$-100.2M
Q2 24
$35.1M
Q1 24
$-29.1M
FCF Margin
MD
MD
TTEC
TTEC
Q4 25
-1.6%
Q3 25
-1.8%
Q2 25
16.7%
Q1 25
3.0%
Q4 24
-1.7%
Q3 24
-18.9%
Q2 24
6.6%
Q1 24
-5.0%
Capex Intensity
MD
MD
TTEC
TTEC
Q4 25
2.1%
Q3 25
2.7%
Q2 25
1.4%
Q1 25
1.0%
Q4 24
1.5%
Q3 24
1.7%
Q2 24
2.7%
Q1 24
2.3%
Cash Conversion
MD
MD
TTEC
TTEC
Q4 25
3.39×
Q3 25
1.91×
Q2 25
3.49×
Q1 25
-5.66×
15.60×
Q4 24
4.36×
-0.24×
Q3 24
4.72×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

TTEC
TTEC

Ttec Engage$444.5M78%
Ttec Digital$125.5M22%

Related Comparisons